One lot of propranolol blood pressure medication recalled over possible metal contamination: what to do if you take it
Breckenridge Pharmaceutical recalled one lot of 60 mg extended-release capsules nationwide in the U.S., with the FDA's knowledge. The risk: small metal fragments. No adverse events have been reported so far.
Photo: Whispyhistory / Wikimedia Commons · CC BY-SA 4.0
Boxes of propranolol tablets from different makers in the UK; not the recalled product. Reference photo: Whispyhistory / Wikimedia Commons (CC BY-SA 4.0).
Drugmaker Breckenridge Pharmaceutical has voluntarily recalled, nationwide in the United States, one lot of propranolol hydrochloride 60 mg extended-release capsules, a medicine used for high blood pressure, because of potential metal contamination. The notice was published on November 16 and the recall is being conducted with the knowledge of the FDA.
The key detail is on the bottle label.
Which product is recalled
- Product: Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg
- Package: 100-count bottle
- NDC: 51991-817-01
- Lot: PK25110035
- Expiration: May 2029
According to the company, the lot was manufactured by Adare Pharma Solutions and distributed to wholesalers and pharmacies nationwide between October 26 and November 4, 2026. It shared an intermediate material suspected to be the source of metal contamination found in a separate lot that was never released to market.
What is the risk
Breckenridge warns that using capsules from the affected lot could cause lacerations of soft tissues in the mouth, esophagus, stomach or intestine. As of the notice, the company said it was not aware of any related adverse events, according to its statement and outlets such as USA Today and NBC Chicago.
What to do if you have it at home
The company asks people to stop taking capsules from that lot, return any unused product to the pharmacy and contact their doctor for advice and a replacement. Do it the same day: MedlinePlus warns not to stop propranolol without talking to your doctor, because stopping it suddenly can cause serious heart problems.
If your bottle has a different lot number, it is not part of this recall. Adverse events can be reported to the FDA's MedWatch program. If in doubt, talk to your doctor or pharmacist.
Read also: Nolotil: el estudio sobre el metamizol en Alicante · Día Mundial de la Diabetes
Sources
For information only. It does not replace advice from a health professional. Medical disclaimer